All News

Kyprolis failed to improve survival in the phase 3 FOCUS trial in patients who had relapse following at least 3 prior regimens.

Scientists at Hopkins are working on developing a test that can rapidly sequence cellular DNA in a blood sample for early diagnosis of cancer, which could have a tremendous potential in asymptomatic subtypes of the disease.

With the speed at which technology advances, it can be surprising that the majority of US medical records are not yet available electronically - but the nation is gradually making the transition to great electronic health record (EHR) use.

CMS provided COA a draft of an episode-based payment model being developed at their Innovation Center. COA has been in collaboration with CMS on developing this model.

The gene, normally expressed only in a developing embryo, was found expressed in several different childhood cancers.

With the aim to authenticate and regulate medical information, Cancer Research UK plans to provide the most up-to-date and accurate healthcare information.

WellPoint Inc is planning on changing its name to Anthem to eliminate brand confusion and better connect with consumers.

Cologuard had received recommendation for premarket approval from a FDA advisory panel back in March.

The concept of a single-payer health system remains somewhat controversial among some legislators, yet Vermont continues to embrace the transition despite the challenges.

Next year, U.S. healthcare providers will be subject to Medicare penalties if they do not meet up to 26 measures for value-based purchasing.

The study, published in the Journal of Clinical Oncology, examined national statistics for the period between 2007 to 2010 for people aged 18-64 of age.

Specialty drugs expected to account for 40% of total prescription spending by 2016, according to Catamaran Corporation.

Using the genome editing tool known as CRISPR, researchers were able to selectively silence two genes in HPV that are responsible for the growth and survival of cervical carcinoma cells.

The approval follows results from the RETRIEVE trial, conducted in patients who had previously responded to Velcade but had relapsed.

Although the overall rate of NSCLC is lower, certain subtypes of the disease fared better than others, the study published in the journal Cancer found.

New research found that the risk of developing breast cancer increased in women who had mutations of a gene related to BRCA2, the PALB2 gene.

Bottom line: Sovaldi will not save the system money. It will cost money-a lot of money-to reduce premature mortality due to chronic hepatitis C infection.

The CMS has removed the provider review version of a new database that details financial relationships between healthcare providers and drug and medical-device manufacturers.

Consumers who missed open enrollment on the state health insurance marketplaces this spring or who are waiting for employer coverage to start don't have to "go bare."

The World Health Organization declared an international public health emergency Friday over the Ebola outbreak in western Africa that has killed almost 1,000 people. The outbreak of the deadly virus is "extraordinary event" and a public health risk to other countries, it said.

Older patients who are diagnosed with HIV/AIDS present a variety of challenges for providers, especially when it comes to controlling their costs of care.

The research, published in the journal Cell, proposes revising treatment based on the molecular constitution of the tumor when it presents itself, rather than the tissue or organ of origin.

According to Sir Andrew Dillon, chief executive of NICE, the high price that Roche is demanding for Kadcyla is beyond the means of NHS to cover.

The study, published in NEJM, proposes enhanced surveillance in women with PALB2 mutations, similar to women harboring BRCA2 mutations.

High rate of hospice survivors, especially in Alabama and Mississippi, have raised doubts about improper practices.

Published in Nature Communications, the study identified a new gene fusion and rearrangement of the estrogen receptor, responsible for the aggressive nature of luminal B breast cancer.

Six of the most prominent healthcare systems in Wisconsin have created a new partnership, jumping on the nationwide bandwagon of forming strategic alliances to share information, while remaining independent.

While a few free health clinics have shut their doors in Arkansas and Washington, most expansion-state non-profit free clinics are reassessing their business strategies.

The Lancet study, conducted in Europe, found a survival benefit with early diagnosis, but does not agree that the benefit outweighs some of the associated risks of the test.